Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03000725 · ClinicalTrials.gov registry record · NA
Adapting Project UPLIFT for Hispanic Patients With Epilepsy II
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT03000725: Completed NA study, sponsored by NYU Langone Health.
NCT03000725 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03000725, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to adapt Project UPLIFT for Hispanic adults with epilepsy and depression. Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a home-based intervention that teaches cognitive and mindfulness skills to people with epilepsy by phone to reduce their depression and improve quality of life (QOL); it was developed at Emory University with CDC funding. The purpose of this study is to adapt Project UPLIFT for Hispanic adults with epilepsy and depression. Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a home-based intervention that teaches cognitive and mindfulness skills to people with epilepsy by phone to reduce their depression and improve quality of life (QOL); it was developed at Emory University with CDC funding.
Primary Outcome
This measure assesses depressive symptoms in the past two weeks based on DSM-IV diagnostic criteria for major depression.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Using Practice and Learning to Increase Favorable Thoughts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2016-10 |
| Est. Completion | 2019-09 |
| Phase | NA |
What the finished NCT03000725 record still lists
NCT03000725 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT03000725 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03000725 about?
NCT03000725 is a clinical study titled "Adapting Project UPLIFT for Hispanic Patients With Epilepsy II". The purpose of this study is to adapt Project UPLIFT for Hispanic adults with epilepsy and depression. Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a home-based intervention that teaches cognitive and mindfulness skills to people with epilepsy by phone to reduce the...
What is the current status of trial NCT03000725?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2016-10. Estimated completion is 2019-09.
What interventions are being tested in trial NCT03000725?
The interventions under investigation include: Usual Care (BEHAVIORAL), Using Practice and Learning to Increase Favorable Thoughts (BEHAVIORAL).
Who is sponsoring clinical trial NCT03000725?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03000725's enrollment target sits among peer trials
72 1089th of 2000 higher than 899 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia